Contrast Media Injectors Market Size, Share & Trends Analysis Report By Product (Injector Systems, Consumables), By Type (Single Head, Dual Head), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
Contrast Media Injectors Market Growth & Trends
The global contrast media injectors market is expected to reach USD 2.08 billion by 2030, registering a CAGR of 7.50% during the forecast period, according to a new report by Grand View Research, Inc. The market is expected to grow because of the rising demand for minimally invasive surgical procedures, along with the increasing usage of consumables for several diagnostic procedures, which are supporting the market growth of contrast media injectors.
COVID-19 had a significant impact on the contrast media injector market, in 2019, with around a 30-40% reduction in sales due to the imposed lockdown and rapid decline in imaging case volume. However, the market is expected to return to peak levels of 2019 by 2022. This is due to the launch of COVID-19 vaccines and ease in restrictions, import & export of raw materials have resumed; therefore, the market is expected to grow at a significant rate over the forecast period.
Technological advancements such as IT-enabled solutions for contrast media injectors, along with growing demand for minimally invasive surgical procedures, are expected to boost the market during the coming years. Furthermore, the large number of intraoperative imaging procedures being performed has further enhanced the demand for these injectors, propelling the market growth.
Contrast Media Injectors Market Report Highlights
- By product, injector systems accounted for the largest market share of 60.9% in 2023, due to its growing application in the diagnosis and treatment of vascular disease, cancer, and others
- By type, single head injectors accounted for the largest market share of 43.60% in 2023, because of their wide usage in the field of angiography, CT, and MRI as well these products are inexpensive
- Based on the application, the radiology segment dominated the market with around 46.94% of the revenue share in 2023, because it is the primary procedure used for the diagnosis of several chronic diseases
- Based on the end-use, the hospitals segment dominated the market with around 68.37% of the revenue share in 2023, due to the fact that these facilities are primary users of the contrast media injectors because of their need to record the rhythm & electrical activity and evaluate the results in detail for clinical & research purposes
- Asia Pacific contrast media injectors market is expected to witness the fastest growth rate at a CAGR of 8.57% over the forecast period. Factors that can be attributed to market growth include the growing geriatric population and an increasing number of surgeries
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Product Segment
- 1.2.2. Type Segment
- 1.2.3. Application Segment
- 1.2.4. End Use Segment
- 1.3. Information analysis
- 1.3.1. Market formulation & data visualization
- 1.4. Data validation & publishing
- 1.5. Information Procurement
- 1.5.1. Primary Research
- 1.6. Information or Data Analysis
- 1.7. Market Formulation & Validation
- 1.8. Market Model
- 1.9. Total Market: CAGR Calculation
- 1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Insights Landscape
- Chapter 3. Contrast Media Injectors Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing Demand For Minimally Invasive Surgeries
- 3.2.1.2. Increasing Application In Neurosurgeries And Orthopedic Surgeries
- 3.2.1.3. Technological Advancement In Contrast Media Injectors
- 3.2.1.4. Growing Number Of Regulatory Approvals
- 3.2.2. Market restraint analysis
- 3.2.2.1. Prolonged Approval Process
- 3.2.2.2. High Cost Of Contrast Media Injectors
- 3.3. Contrast Media Injectors Market Analysis Tools
- 3.3.1. Industry Analysis – Porter’s
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
- Chapter 4. Contrast Media Injectors Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Contrast Media Injectors Market Product Movement Analysis
- 4.3. Global Contrast Media Injectors Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Injector Systems
- 4.4.1. Injector systems market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. CT Injector Systems
- 4.4.2.1. CT injector systems market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3. MRI Injector Systems
- 4.4.3.1. MRI injector systems market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.4. Cardiovascular/Angiography Injector Systems
- 4.4.4.1. Cardiovascular/angiography systems market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Consumables
- 4.5.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.2. Tubing
- 4.5.2.1. Tubing market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.3. Syringe
- 4.5.3.1. Syringe market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.4. Interventional Radiology
- 4.5.4.1. Interventional Radiology market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 5. Contrast Media Injectors Market: Type Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Contrast Media Injectors Market Type Movement Analysis
- 5.3. Global Contrast Media Injectors Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
- 5.4. Single-head Injectors
- 5.4.1. Single-head Injectors market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Dual-head Injectors
- 5.5.1. Dual-head injectors market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6. Syringeless Injectors
- 5.6.1. Syringeless injectors market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 6. Contrast Media Injectors Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Contrast Media Injectors Market Application Movement Analysis
- 6.3. Global Contrast Media Injectors Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 6.4. Radiology
- 6.4.1. Radiology market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Interventional Cardiology
- 6.5.1. Interventional cardiology market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Interventional Radiology
- 6.6.1. Interventional radiology market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 7. Contrast Media Injectors Market: End Use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Global Contrast Media Injectors Market End Use Movement Analysis
- 7.3. Global Contrast Media Injectors Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 7.4. Hospitals
- 7.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5. Diagnostic Centers
- 7.5.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. Ambulatory Surgery Centers
- 7.6.1. Contract research organizations market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 8. Contrast Media Injectors Market: Regional Estimates & Trend Analysis
- 8.1. Regional Market Share Analysis, 2023 & 2030
- 8.2. Regional Market Dashboard
- 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 8.4. North America
- 8.4.1. U.S.
- 8.4.1.1. Key country dynamics
- 8.4.1.2. Competitive scenario
- 8.4.1.3. Regulatory framework
- 8.4.1.4. Reimbursement scenario
- 8.4.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.2. Canada
- 8.4.2.1. Key country dynamics
- 8.4.2.2. Competitive scenario
- 8.4.2.3. Regulatory framework
- 8.4.2.4. Reimbursement scenario
- 8.4.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.3. Mexico
- 8.4.3.1. Key country dynamics
- 8.4.3.2. Competitive scenario
- 8.4.3.3. Regulatory framework
- 8.4.3.4. Reimbursement scenario
- 8.4.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5. Europe
- 8.5.1. UK
- 8.5.1.1. Key country dynamics
- 8.5.1.2. Competitive scenario
- 8.5.1.3. Regulatory framework
- 8.5.1.4. Reimbursement scenario
- 8.5.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.2. Germany
- 8.5.2.1. Key country dynamics
- 8.5.2.2. Competitive scenario
- 8.5.2.3. Regulatory framework
- 8.5.2.4. Reimbursement scenario
- 8.5.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.3. France
- 8.5.3.1. Key country dynamics
- 8.5.3.2. Competitive scenario
- 8.5.3.3. Regulatory framework
- 8.5.3.4. Reimbursement scenario
- 8.5.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.4. Italy
- 8.5.4.1. Key country dynamics
- 8.5.4.2. Competitive scenario
- 8.5.4.3. Regulatory framework
- 8.5.4.4. Reimbursement scenario
- 8.5.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.5. Spain
- 8.5.5.1. Key country dynamics
- 8.5.5.2. Competitive scenario
- 8.5.5.3. Regulatory framework
- 8.5.5.4. Reimbursement scenario
- 8.5.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.6. Norway
- 8.5.6.1. Key country dynamics
- 8.5.6.2. Competitive scenario
- 8.5.6.3. Regulatory framework
- 8.5.6.4. Reimbursement scenario
- 8.5.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.7. Sweden
- 8.5.7.1. Key country dynamics
- 8.5.7.2. Competitive scenario
- 8.5.7.3. Regulatory framework
- 8.5.7.4. Reimbursement scenario
- 8.5.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.8. Denmark
- 8.5.8.1. Key country dynamics
- 8.5.8.2. Competitive scenario
- 8.5.8.3. Regulatory framework
- 8.5.8.4. Reimbursement scenario
- 8.5.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6. Asia Pacific
- 8.6.1. Japan
- 8.6.1.1. Key country dynamics
- 8.6.1.2. Competitive scenario
- 8.6.1.3. Regulatory framework
- 8.6.1.4. Reimbursement scenario
- 8.6.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.2. China
- 8.6.2.1. Key country dynamics
- 8.6.2.2. Competitive scenario
- 8.6.2.3. Regulatory framework
- 8.6.2.4. Reimbursement scenario
- 8.6.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.3. India
- 8.6.3.1. Key country dynamics
- 8.6.3.2. Competitive scenario
- 8.6.3.3. Regulatory framework
- 8.6.3.4. Reimbursement scenario
- 8.6.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.4. Australia
- 8.6.4.1. Key country dynamics
- 8.6.4.2. Competitive scenario
- 8.6.4.3. Regulatory framework
- 8.6.4.4. Reimbursement scenario
- 8.6.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.5. South Korea
- 8.6.5.1. Key country dynamics
- 8.6.5.2. Competitive scenario
- 8.6.5.3. Regulatory framework
- 8.6.5.4. Reimbursement scenario
- 8.6.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.6. Thailand
- 8.6.6.1. Key country dynamics
- 8.6.6.2. Competitive scenario
- 8.6.6.3. Regulatory framework
- 8.6.6.4. Reimbursement scenario
- 8.6.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7. Latin America
- 8.7.1. Brazil
- 8.7.1.1. Key country dynamics
- 8.7.1.2. Competitive scenario
- 8.7.1.3. Regulatory framework
- 8.7.1.4. Reimbursement scenario
- 8.7.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.2. Argentina
- 8.7.2.1. Key country dynamics
- 8.7.2.2. Competitive scenario
- 8.7.2.3. Regulatory framework
- 8.7.2.4. Reimbursement scenario
- 8.7.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8. MEA
- 8.8.1. South Africa
- 8.8.1.1. Key country dynamics
- 8.8.1.2. Competitive scenario
- 8.8.1.3. Regulatory framework
- 8.8.1.4. Reimbursement scenario
- 8.8.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.2. Saudi Arabia
- 8.8.2.1. Key country dynamics
- 8.8.2.2. Competitive scenario
- 8.8.2.3. Regulatory framework
- 8.8.2.4. Reimbursement scenario
- 8.8.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.3. UAE
- 8.8.3.1. Key country dynamics
- 8.8.3.2. Competitive scenario
- 8.8.3.3. Regulatory framework
- 8.8.3.4. Reimbursement scenario
- 8.8.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.4. Kuwait
- 8.8.4.1. Key country dynamics
- 8.8.4.2. Competitive scenario
- 8.8.4.3. Regulatory framework
- 8.8.4.4. Reimbursement scenario
- 8.8.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 9. Competitive Landscape
- 9.1. Company/Competition Categorization
- 9.2. Strategy Mapping
- 9.3. Company Market Position Analysis, 2023
- 9.4. Company Profiles/Listing
- 9.4.1. Bayer HealthCare LLC
- 9.4.1.1. Company overview
- 9.4.1.2. Financial performance
- 9.4.1.3. Product benchmarking
- 9.4.1.4. Strategic initiatives
- 9.4.2. Bracco Group
- 9.4.2.1. Company overview
- 9.4.2.2. Financial performance
- 9.4.2.3. Product benchmarking
- 9.4.2.4. Strategic initiatives
- 9.4.3. Ulrich Medical
- 9.4.3.1. Company overview
- 9.4.3.2. Financial performance
- 9.4.3.3. Product benchmarking
- 9.4.3.4. Strategic initiatives
- 9.4.4. Guerbet Group
- 9.4.4.1. Company overview
- 9.4.4.2. Financial performance
- 9.4.4.3. Product benchmarking
- 9.4.4.4. Strategic initiatives
- 9.4.5. Medtron AG
- 9.4.5.1. Company overview
- 9.4.5.2. Financial performance
- 9.4.5.3. Product benchmarking
- 9.4.5.4. Strategic initiatives
- 9.4.6. Nemoto Kyorindo Co., Ltd.
- 9.4.6.1. Company overview
- 9.4.6.2. Financial performance
- 9.4.6.3. Product benchmarking
- 9.4.6.4. Strategic initiatives
- 9.4.7. Hong Kong Medi Co Limited
- 9.4.7.1. Company overview
- 9.4.7.2. Financial performance
- 9.4.7.3. Product benchmarking
- 9.4.7.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook